← All trials
NCT06560489
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 2, 2024
- Primary completion
- Jan 20, 2025
- Completion date
- May 20, 2025
- First posted
- Aug 19, 2024
- Last posted
- Sep 19, 2024
- Enrollment
- 40
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Shanxi Kangbao Pharmaceutical companyLead sponsor
- Zhengzhou UniversityOfficial
- Chinese Academy of Medical SciencesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.